Muscle Stimulator Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Functional Electrical Stimulators [FES], Neuromuscular Electrical Stimulators [NMES], Transcutaneous Electrical Nerve Stimulation Devices (TENS), and Others), By Type (Implantable and External), By Application (Musculoskeletal Disorders, Pain Management, Neurological Disorders, and Others), By End User (Hospitals, Physiotherapy & Rehabilitation Clinics, Homecare Settings, and Others), and Regional Forecast, 2026-2034

The global muscle stimulator market size was valued at USD 0.82 billion in 2025. The market is projected to grow from USD 0.85 billion in 2026 to USD 1.11 billion by 2034, exhibiting a CAGR of 3.36% during the forecast period.

A muscle stimulator is a medical device used to treat impaired muscle functioning caused due to various medical conditions such as stroke, muscle injury, major surgery, and others. These devices are also intended to prevent muscle atrophy, treat muscle spasms, relieve pain, and strengthen abdominal muscles. The growing burden of musculoskeletal disorders limiting mobility among patients is one of the predominant factors raising the demand for these devices.

• According to data published by the World Health Organization (WHO) in 2022, an estimated 1.71 billion people across the globe are suffering from musculoskeletal disorders, of which low back pain is the leading cause of disability worldwide. Moreover, it has been shown through various research that muscle stimulator devices such as transcutaneous electrical stimulators are effective in reducing pain intensity, thus raising the demand for these devices among the patient population.

Moreover, the launch of advanced muscle stimulators by the players to tone, strengthen, and firm the body's abdominal muscles and get the core into a proper shape is also anticipated to increase their adoption rate among those who are conscious regarding their aesthetics and looks.

• For instance, in December 2021, Cutera, Inc., one of the prominent players in energy-based aesthetic devices, launched a next-generation muscle sculpting device, truSculpt flex. The device mechanism is based on the company's proprietary multi-directional stimulation to offer muscle toning, firming, and strengthening results in a fraction of treatment time.

Impact of COVID-19 on the Muscle Stimulators Market

The COVID-19 pandemic had a significant impact on the muscle stimulator market. The market witnessed a decline during the initial phase of the pandemic owing to the disruption in the demand and supply chain and the reduction in patient visits to physiotherapy clinics, among others. However, various studies were carried out to demonstrate the impact of muscle stimulation in COVID-19 patients to strengthen their muscles and improve muscle functionality.

• According to a study published in NCBI in 2022, it was shown that rehabilitation with neuromuscular electrical stimulation (NMES) improved muscle functionality and also strengthened the muscles of patients suffering from sepsis and septic shock associated with critical COVID-19.
• Moreover, Avazzia, Inc, in collaboration with Baylor College of Medicine, initiated a phase I clinical trial in December 2020 to study the effectiveness of lower extremity electrical stimulation (EE) therapy to prevent muscular weakness and complications in COVID-19 patients.

Additionally, many companies received emergency use authorization for muscle stimulators to improve COVID-19 patient conditions. For instance, in May 2020, Liberate Medical received emergency use authorization (EMA) from the U.S. FDA for VentFree Respiratory Muscle Stimulator intended to reduce atrophy of the abdominal wall muscles among adult patients suffering from COVID-19.

Key Insights

The report will cover the following key insights:

• Prevalence of Musculoskeletal Disorders, Key Countries, 2022.
• Prevalence of Neurological Disorders, Key Countries, 2022.
• New Product Launches, Key Players.
• Key Industry Developments (Mergers Acquisitions, and Partnerships).
• Impact of COVID-19 on the market.

Analysis by Product Type

Among the product type segment, functional electrical stimulators (FES) accounted for a significant market share in the global muscle stimulators market. The growing prevalence of the population living with foot drop conditions as a result of rising cases of stroke, traumatic brain injury, multiple sclerosis, and other neurological disorders is one of the key factors increasing the adoption of these devices. Furthermore, approval and launch of FES devices by companies operating in the market to cater to the rising demand among patients suffering from various neurological disorders is anticipated to propel the muscle stimulator market during the forecast period.

• For instance, in November 2020, Bioness Inc., recently acquired by Bioventus, commercially launched the L100 Go system, an FES system for patients suffering from foot drop associated to motor neuron disease or injury.

Regional Analysis

To gain extensive insights into the market, Download for Customization

North America is projected to hold the lion's share in the muscle stimulators market and will continue with its position in the forthcoming years. The growing prevalence of the target patient population in the region, rising initiatives by the key players in strengthening their foothold in the region, expansion of the product offering by manufacturers, and availability of reimbursement for these devices are a few factors augmenting the market.

• For instance, in November 2022, MyndTec Inc., a player focused towards developing neurological rehabilitation devices, launched a new FES product, MyndStep, to cater to foot drop ailments. The company has also entered into a distribution and supply agreement with Guangzhou Longest Science & Technology Co. Ltd. to distribute the product in the U.S. and Canada.

Moreover, the market for muscle stimulators in Asia Pacific is projected to exhibit lucrative growth during the forecast period. The growing prevalence of musculoskeletal disorders, traumatic brain injuries, and neurological disorders, among others, are raising the demand for these devices.

• According to Brain Foundation, one of Australia's largest independent brain and spinal injury research funders, approximately 56,000 Australians have strokes each year.

Additionally, improving healthcare infrastructure in the region, such as establishing new clinics and hospitals to cater to the rising patient population, various awareness programs, and launching new products, among others, are fueling the market growth in the region.

• For instance, in 2021, a chain of physiotherapy clinics, PhysioTattava, was founded in India to offer pain management solutions through physiotherapy and other non-invasive procedures.

Hence, all the factors mentioned above are expected to support the growth of the muscle stimulators market in various regions.

Key Players Covered

The report will include the profiles of key players such as Bioventus, HASOMED GmbH, Omron Corporation, DJO, LLC, Zynex Medical, Restorative Therapies, Beurer GmbH, PlayMakar, and others.

Segmentation

Key Industry Developments

• March 2022: Cionic, a company focused on developing products for patients suffering from mobility disorders, received FDA clearance for the lightweight leg-worn Cionic Neural Sleeve with functional electrical stimulation to improve foot drop and leg muscle weakness.
• December 2021: Sky Medical Technology Ltd. received FDA approval for its neuromuscular electrical stimulator device, geko, to improve microcirculatory blood flow in the lower limb of patients with venous insufficiency or ischemia.
• June 2021: Medline Industries, LP entered into an exclusive collaboration with Spectramed to optimize the treatment of patients suffering from dysphagia. Through this collaboration, Medline announced to sell its therapy device utilizing neuromuscular electrical stimulation (NMES) and surface electromyography (sEMG) combined to aid patient treatment.